Condition category
Circulatory System
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
Not yet recruiting

Plain English Summary

Background and study aims
High blood pressure increases the risk of heart disease and stroke and is a major cause of ill-health in the UK. There is evidence that eating too much salt can increase your blood pressure. The recommended salt intake for adults is less than 6g/day, but the average adult in the UK eats 8.1g/day. The majority of the salt people eat comes from packaged or processed foods. For many high-salt products there is a similar, lower-salt alternative but it can be difficult for shoppers to quickly identify these alternatives. The aim of this study is to test a new program to help people with high blood pressure to reduce their salt intake, by helping them choose lower-salt products when supermarket shopping.

Who can participate?
Adults with high blood pressure who regularly shop in a supermarket and own a smartphone.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group take part in the program to help them lower their salt intake. This consists of advice from a healthcare professional about salt and its effect on blood pressure and instructions to download and use a smartphone app which suggests lower-salt alternatives when grocery shopping. Those in the second group receive an information leaflet which contains tips and tools to help reduce salt intake.

What are the possible benefits and risks of participating?
Participants may benefit from reducing their salt intake. There are no notable risks involved with participating.

Where is the study run from?
The study is being run by Nuffield Department of Primary Care Health Sciences, University of Oxford and takes place in GP practices in Oxfordshire and the Thames Valley (UK)

When is the study starting and how long is it expected to run for?
November 2016 to March 2019

Who is funding the study?
British Heart Foundation (UK)

Who is the main contact?
Ms Sarah Payne Riches

Trial website

Contact information



Primary contact

Ms Sarah Payne Riches


Contact details

Radcliffe Observatory Quarter
Woodstock Road
United Kingdom
+44 1865 289300

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Randomised controlled feasibility trial of a complex behavioural intervention to reduce salt intake among people with high blood pressure



Study hypothesis

The aim of this study is to test a new intervention to help people with high blood pressure to reduce their salt intake, by helping them choose lower-salt products when supermarket shopping.

Ethics approval

South Central – Hampshire B REC, 17/03/2017, ref: 17/SC/0098

Study design

Randomised; Interventional; Design type: Treatment, Prevention, Psychological & Behavioural, Complex Intervention

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet


Specialty: Primary Care, Primary sub-specialty: Cardiovascular disease; UKCRC code/ Disease: Cardiovascular/ Hypertensive diseases


Participants will be randomised to one of two groups using computer generated block randomisation.

Intervention: Participants will receive a behavioural intervention consisting of one session of brief dietary and motivational advice, to be delivered by a health care professional (HCP) in primary care. In addition, participants will receive ongoing support at the point of choice while shopping using a mobile phone application (app), which will suggest lower salt alternatives, enable self-monitoring and provide feedback on salt content of purchases. The brief advice session by the HCP will last approximately 20 minutes. The intervention period will be 6 weeks.

Control: Participants will receive an information and advice leaflet by post. This leaflet is produced by the British Heart Foundation and is called Cut Down on Salt and contains tips and tools to help reduce salt intake.

There will be one follow up assessment which will occur in the week following the 6 week intervention period. Baseline assessment measures will be repeated and all participants will be also be asked to complete a short post-intervention questionnaire to assess aspects of the intervention (or control) they received.

Intervention type



Drug names

Primary outcome measures

Feasibility outcomes:
1. Study follow -up rate will be measured as the percentage of participants, in each arm of the study who attend the follow-up session within within 4 weeks from the end of the intervention period.
2. Intervention fidelity will be measured, on completion of delivery of all intervention advice sessions, as the mean percentage of pre-specified components of the intervention advice session which are delivered by the practice nurse(s). The fidelity with which the intervention was implemented will be tested by asking nurses to audio-record the consultation which is then compared against a checklist of the components required by the protocol.
3. Intervention usage (app usage) will be measured as the number of participants who use the app to scan products on at least one occasion by the end of month one of the intervention period

Secondary outcome measures

1. Salt content of purchased foods is measured as salt in g/100g of total product weight, assessed through scanning of purchased product bar-codes and linking to a food and nutrient information database during a baseline period of two weeks before the intervention and over the intervention period
2. Sodium intake is measured using a 24 hour urinary sodium test, at baseline and at the 6 week follow up appointment
3. Blood pressure is measured using an electronic BP monitor at baseline and at the 6 week follow up

Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

1. Participants’ most recent blood pressure reading in the past 2 years is 140/90 mmHg or higher (taken in clinic, with or without subsequent ambulatory blood pressure monitoring daytime average or home blood pressure monitoring average blood pressure of 135/85 mmHg or higher)
2. Not currently taking hypertension medication
3. Participant is willing and able to give informed consent for participation in the study
4. Male or Female, aged between 18 and 80 years
5. English speaking
6. Who regularly shop in a supermarket (excluding online supermarkets), spending at least £25 at least once a fortnight
7. Own a smartphone (android or iOS)
8. Who express a desire for support to improve the nutritional quality of their diet to reduce their CVD risk

Participant type


Age group




Target number of participants

Planned Sample Size: 40; UK Sample Size: 40

Participant exclusion criteria

1. Already on a clinician supervised diet or a restricted diet
2. Unwilling to make dietary changes
3. Are currently using or have used the Foodswitch or Saltswitch apps previously
4. Unable to read and understand the instructions provided in English
5. Currently on blood pressure lowering medication
6. Currently on any medication that may lead to hyponatraemia or fluid retention
7. Existing or recent cardiovascular conditions: heart attack or stroke within the last 3 months, heart failure of grade II New York Heart Association and more severe, or prolonged QT syndrome, angina, arrhythmia or atrial fibrillation.
8. Currently participating in another study (including follow-up)
9. Patients that the GP judges not able to meet the demands of the study or unlikely to comply with study procedures as stated in the protocol
10. They are planning on going away from home (holiday or other) for more than 4 consecutive days during the 6 week intervention period

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Nuffield Department of Primary Care Health Sciences
University of Oxford Radcliffe Observatory Quarter Woodstock Road
United Kingdom

Sponsor information


University of Oxford

Sponsor details

Clinical Trials and Research Governance Joint Research Office
Block 60
Churchill Hospital
United Kingdom
+44 1865 289300

Sponsor type

Hospital/treatment centre



Funder type


Funder name

British Heart Foundation

Alternative name(s)


Funding Body Type

private sector organisation

Funding Body Subtype



United Kingdom

Results and Publications

Publication and dissemination plan

1. Study results will be communicated to study participants and members of the public involved in the research through email newsletters and press releases targeted to the specific audience
2. Planned publication of study results in academic peer-reviewed journals and through presentations at relevant conferences

IPD Sharing statement:
The data will be in a non-publically available repository (University of Oxford).

Intention to publish date


Participant level data

Stored in repository

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes

22/01/18: The following changes were made: 1. Recruitment start date was changed from 04/09/2017 to 30/05/2018. 2. Recruitment end date was changed from 04/12/2017 to 30/10/2018. 3. Overall trial end date was changed from 04/05/2018 to 30/03/2019. 4. Intention to publish date was changed from 04/05/2019 to 30/09/2019. 11/05/2017: Internal review.